查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1455303

2024 年药品供应链管理全球市场报告

Pharmaceutical Supply Chain Management Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年药品供应链管理市场规模将大幅成长。预计到 2028 年将以 8.7% 的复合年增长率 (CAGR) 增长至 36.3 亿美元。预测期内药品供应链管理的预期成长可归因于多种因素。这些措施包括增加精准医疗的采用、注重供应链内的弹性规划、加强资料安全措施、与电子商务平台整合、引入即时监控和视觉化解决方案以及强调循环经济等。业界的倡议。预测期内预计的主要趋势包括数位转型工作、持续的技术进步、整个供应链的协作和可见性的增强、对环境永续性的高度关注，以及整合分析和人工智慧以及引入区块链技术以提高透明度等。和安全。

药品需求的增加预计将推动药品供应链管理市场的成长。药品，包括为预防、治疗和管理各种疾病而开发、製造和分销的药品，依赖有效的药品供应链管理来实现高效的生产、分销和监控。这确保了及时获得基本医疗保健产品。例如，根据欧洲製药工业协会联合会2023年6月的资料，欧洲药品产量将从2021年的3,473.1亿美元（3,239.5亿欧元）增加到2022年的3,642.6亿美元（340亿欧元）。成长4.88%。因此，医药产品需求的上升可望刺激医药供应链管理市场。

慢性病盛行率的增加预计将有助于药品供应链管理市场的成长。慢性病的特征是长期病情持续超过三个月，需要有效的药品供应链管理，以确保一致、有效率地提供药物和治疗。这种方法可以帮助减少延误、控製成本并确保及时获得慢性病管理所需的药物。美国国立卫生研究院 (NIH) 2023 年 1 月报告称，研究表明，美国劳动年龄人群的慢性病发病率预计将大幅上升，50 岁以上的人至少与一名慢性病预计100人以上的人数将增加99.5 %。因此，慢性病盛行率的增加将成为药品供应链管理市场的主要驱动因素。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球药品供应链管理市场的驱动因素与阻碍因素
    • 市场驱动力
    • 市场限制
  • 2018-2023 年全球药品供应链管理市场规模、表现与成长
  • 全球医药供应链管理市场规模及成长预测，2023-2028、2033

第六章市场区隔

  • 全球药品供应链管理市场，按组成部分、绩效和预测细分，2018-2023、2023-2028、2033
  • 解决方案
  • 服务
  • 全球药品供应链管理市场，依部署模式、绩效及预测细分，2018-2023、2023-2028、2033
  • 本地
  • 云端基础
  • 全球药品供应链管理市场，依最终用途、绩效及预测细分，2018-2023、2023-2028、2033
  • 保健品製造商
  • 医疗服务提供方
  • 代理销售
  • 物流

第 7 章 区域与国家分析

  • 全球药品供应链管理市场，按地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球药品供应链管理市场，依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 医药供应链管理市场竞争格局
  • 医药供应链管理市场公司概况
    • McKesson Corporation
    • AmerisourceBergen Corporation
    • Cardinal Health Inc.
    • Oracle Corporation
    • SAP SE

第三十一章 其他重大及创新企业

  • DSV Panalpina
  • UPS Healthcare
  • Parexel International Corporation
  • Spectrum Health Medical Group
  • Vizient Inc
  • Catalent Inc.
  • Infor Inc.
  • Epicor Software Corporation
  • Alvogen Inc.
  • Vetter Pharma International GmbH
  • Almac Group
  • Manhattan Associates Inc.
  • Global Healthcare Exchange LLC
  • CryoPDP
  • Tecsys Inc.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r16304

Pharmaceutical supply chain management involves the strategic planning, implementation, and control of the flow of pharmaceutical products and related information from manufacturers to end-users. The primary goal is to ensure the secure distribution of pharmaceuticals while maintaining product quality, safety, and compliance with regulatory requirements.

The main components of pharmaceutical supply chain management include solutions and services. Solutions encompass products, services, or strategic approaches designed to address specific challenges faced by pharmaceutical organizations. These solutions may involve a combination of resources, expertise, or technology. The deployment modes for these solutions can be either on-premise or cloud-based. Pharmaceutical supply chain management is utilized by various end-users, including healthcare manufacturers, healthcare providers, distributors, and logistics entities.

The pharmaceutical supply chain management market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical supply chain management market statistics, including the pharmaceutical supply chain management industry global market size, regional shares, competitors with pharmaceutical supply chain management market share, detailed pharmaceutical supply chain management market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical supply chain management industry. This pharmaceutical supply chain management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical supply chain management market size has grown strongly in recent years. It will grow from $2.36 billion in 2023 to $2.6 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The growth observed during the historical period in pharmaceutical supply chain management can be attributed to several factors. These include a heightened focus on regulatory compliance, the globalization of pharmaceutical operations, increased attention to risk management, a growing demand for personalized medicine, and a greater emphasis on sustainability practices within the supply chain. These factors collectively contributed to the evolution and advancement of pharmaceutical supply chain management during that period.

The pharmaceutical supply chain management market size is expected to see strong growth in the next few years. It will grow to $3.63 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The anticipated growth in the forecast period in pharmaceutical supply chain management can be attributed to various factors. These include the increasing adoption of precision medicine, a focus on resilience planning within the supply chain, enhanced measures for data security, integration with e-commerce platforms, the implementation of real-time monitoring and visibility solutions, and a growing emphasis on circular economy initiatives within the industry. Major trends expected in the forecast period encompass digital transformation initiatives, continuous technological advancements, increased collaboration and visibility across the supply chain, a strong focus on environmental sustainability, the integration of advanced analytics and artificial intelligence, and the adoption of blockchain technology to enhance transparency and security.

The increasing demand for pharmaceutical products is poised to drive the growth of the pharmaceutical supply chain management market. Pharmaceutical products, which encompass medications and drugs developed, manufactured, and distributed for the prevention, treatment, or management of various medical conditions, rely on effective pharmaceutical supply chain management for efficient production, distribution, and monitoring. This ensures timely access to essential healthcare products. For example, data from the European Federation of Pharmaceutical Industries and Associations in June 2023 indicates that the production value of pharmaceuticals in Europe rose from 347.31 billion USD (323,950 million euros) in 2021 to 364.26 billion USD (340,000 million euros) in 2022, representing a 4.88% increase. Hence, the growing demand for pharmaceutical products is expected to fuel the pharmaceutical supply chain management market.

The increasing prevalence of chronic diseases is anticipated to contribute to the growth of the pharmaceutical supply chain management market. Chronic diseases, characterized by long-lasting medical conditions persisting for three months or more, necessitate effective pharmaceutical supply chain management for a consistent and efficient flow of medications and treatments. This approach helps reduce delays, control costs, and ensure the timely availability of medications crucial for managing chronic conditions. As reported by the National Institutes of Health (NIH) in January 2023, research anticipates a substantial increase in the incidence of chronic illnesses within the U.S. working-age demographic, projecting a 99.5% surge in individuals aged 50 and above with at least one chronic disease between 2020 and 2035. Thus, the growing prevalence of chronic diseases is a key driver for the pharmaceutical supply chain management market.

Security issues within weak supply chain management are anticipated to impede the growth of the pharmaceutical supply chain management market. Weak supply chain management, particularly vulnerabilities such as data breaches, acts as a hindrance, limiting the market's expansion. Such security issues undermine data integrity and confidentiality, raise concerns about product safety and regulatory compliance, and have a negative impact on overall market growth. As reported in October 2022 by Check Point Software Technologies, a US-based software company, the third quarter of 2022 witnessed a significant global increase in cyberattacks, with the average weekly attacks per organization surpassing 1,130. The healthcare sector, including pharmaceuticals, was particularly targeted for ransomware, affecting one in 42 organizations, marking a 5% increase year-over-year. Consequently, security issues within weak supply chain management, notably data breaches, pose challenges to the pharmaceutical supply chain management market.

Key players in the pharmaceutical supply chain management market are actively developing innovative products such as multi-enterprise supply chain work management solutions to streamline processes and enhance collaboration across the pharmaceutical supply chain. Multi-enterprise supply chain work management solutions are specialized software or platforms designed to optimize various supply chain processes across multiple organizations within the pharmaceutical sector. For example, in April 2022, TraceLink Inc., a US-based company providing supply chain work management solutions, introduced the TraceLink supply chain work management solution-a multi-enterprise solution for the healthcare and life sciences industries. This solution aims to facilitate collaborative networks among companies and their trading partners, enhancing the performance of integrated supply planning and execution processes. It effectively manages supply chain issues and planning exceptions, such as material shortages, short shipments, and forecast changes. The solution offers actionable visibility and customizable business process templates for supply chain management, leading to improved fill rates, cost reduction, and enhanced supply plan performance.

In March 2022, Symplr Software LLC, a US-based company specializing in the development of governance, risk, and compliance management software for healthcare facilities, successfully acquired GreenLight Medical for an undisclosed amount. This strategic acquisition is intended to bolster Symplr's healthcare operations portfolio by integrating the specialized medical supply chain management software developed by GreenLight. By incorporating GreenLight's expertise and solutions, Symplr aims to offer its clients enhanced services in the supply chain management sector. This initiative seeks to address the challenges faced by healthcare organizations in supply procurement. GreenLight Medical, the acquired entity, is a US-based provider of healthcare supply chain management solutions.

Major companies operating in the pharmaceutical supply chain management market report are McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health Inc., Oracle Corporation, SAP SE, DSV Panalpina, UPS Healthcare, Parexel International Corporation, Spectrum Health Medical Group, Vizient Inc, Catalent Inc., Infor Inc., Epicor Software Corporation, Alvogen Inc., Vetter Pharma International GmbH , Almac Group, Manhattan Associates Inc., Global Healthcare Exchange LLC, CryoPDP, Tecsys Inc., Arvato Supply Chain Solutions, Terso Solution, Logitag Systems, Jump Technologies, Chain.io Inc.

Asia-Pacific was the largest region in the pharmaceutical supply chain management market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical supply chain management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical supply chain management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The pharmaceutical supply chain management market includes revenues earned by entities by providing services such as logistics and distribution, cold chain management, inventory management, and quality control and assurance services that are used to optimize the pharmaceutical supply chain for the delivery of vital medications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The pharmaceutical supply chain management market consists of sales of cold chain equipment, warehouse automation systems, and automated guided vehicles. to provide pharmaceutical companies with opportunities to optimize the supply chain operations of pharmaceutical products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Supply Chain Management Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical supply chain management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical supply chain management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical supply chain management market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Component: Solution; Service
  • 2) By Deployment Mode: On-Premise; Cloud Based
  • 3) By End-Use: Healthcare Manufacturers; Healthcare Providers; Distributors; Logistics
  • Companies Mentioned: McKesson Corporation; AmerisourceBergen Corporation; Cardinal Health Inc.; Oracle Corporation; SAP SE
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Supply Chain Management Market Characteristics

3. Pharmaceutical Supply Chain Management Market Trends And Strategies

4. Pharmaceutical Supply Chain Management Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Pharmaceutical Supply Chain Management Market Size and Growth

  • 5.1. Global Pharmaceutical Supply Chain Management Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Pharmaceutical Supply Chain Management Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Pharmaceutical Supply Chain Management Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmaceutical Supply Chain Management Market Segmentation

  • 6.1. Global Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Solution
  • Service
  • 6.2. Global Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • On-Premise
  • Cloud Based
  • 6.3. Global Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Healthcare Manufacturers
  • Healthcare Providers
  • Distributors
  • Logistics

7. Pharmaceutical Supply Chain Management Market Regional And Country Analysis

  • 7.1. Global Pharmaceutical Supply Chain Management Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Pharmaceutical Supply Chain Management Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmaceutical Supply Chain Management Market

  • 8.1. Asia-Pacific Pharmaceutical Supply Chain Management Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmaceutical Supply Chain Management Market

  • 9.1. China Pharmaceutical Supply Chain Management Market Overview
  • 9.2. China Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmaceutical Supply Chain Management Market

  • 10.1. India Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmaceutical Supply Chain Management Market

  • 11.1. Japan Pharmaceutical Supply Chain Management Market Overview
  • 11.2. Japan Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmaceutical Supply Chain Management Market

  • 12.1. Australia Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmaceutical Supply Chain Management Market

  • 13.1. Indonesia Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmaceutical Supply Chain Management Market

  • 14.1. South Korea Pharmaceutical Supply Chain Management Market Overview
  • 14.2. South Korea Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmaceutical Supply Chain Management Market

  • 15.1. Western Europe Pharmaceutical Supply Chain Management Market Overview
  • 15.2. Western Europe Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmaceutical Supply Chain Management Market

  • 16.1. UK Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmaceutical Supply Chain Management Market

  • 17.1. Germany Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmaceutical Supply Chain Management Market

  • 18.1. France Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmaceutical Supply Chain Management Market

  • 19.1. Italy Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmaceutical Supply Chain Management Market

  • 20.1. Spain Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmaceutical Supply Chain Management Market

  • 21.1. Eastern Europe Pharmaceutical Supply Chain Management Market Overview
  • 21.2. Eastern Europe Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmaceutical Supply Chain Management Market

  • 22.1. Russia Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmaceutical Supply Chain Management Market

  • 23.1. North America Pharmaceutical Supply Chain Management Market Overview
  • 23.2. North America Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmaceutical Supply Chain Management Market

  • 24.1. USA Pharmaceutical Supply Chain Management Market Overview
  • 24.2. USA Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmaceutical Supply Chain Management Market

  • 25.1. Canada Pharmaceutical Supply Chain Management Market Overview
  • 25.2. Canada Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmaceutical Supply Chain Management Market

  • 26.1. South America Pharmaceutical Supply Chain Management Market Overview
  • 26.2. South America Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmaceutical Supply Chain Management Market

  • 27.1. Brazil Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmaceutical Supply Chain Management Market

  • 28.1. Middle East Pharmaceutical Supply Chain Management Market Overview
  • 28.2. Middle East Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmaceutical Supply Chain Management Market

  • 29.1. Africa Pharmaceutical Supply Chain Management Market Overview
  • 29.2. Africa Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmaceutical Supply Chain Management Market Competitive Landscape And Company Profiles

  • 30.1. Pharmaceutical Supply Chain Management Market Competitive Landscape
  • 30.2. Pharmaceutical Supply Chain Management Market Company Profiles
    • 30.2.1. McKesson Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. AmerisourceBergen Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Cardinal Health Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Oracle Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. SAP SE
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Pharmaceutical Supply Chain Management Market Other Major And Innovative Companies

  • 31.1. DSV Panalpina
  • 31.2. UPS Healthcare
  • 31.3. Parexel International Corporation
  • 31.4. Spectrum Health Medical Group
  • 31.5. Vizient Inc
  • 31.6. Catalent Inc.
  • 31.7. Infor Inc.
  • 31.8. Epicor Software Corporation
  • 31.9. Alvogen Inc.
  • 31.10. Vetter Pharma International GmbH
  • 31.11. Almac Group
  • 31.12. Manhattan Associates Inc.
  • 31.13. Global Healthcare Exchange LLC
  • 31.14. CryoPDP
  • 31.15. Tecsys Inc.

32. Global Pharmaceutical Supply Chain Management Market Competitive Benchmarking

33. Global Pharmaceutical Supply Chain Management Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmaceutical Supply Chain Management Market

35. Pharmaceutical Supply Chain Management Market Future Outlook and Potential Analysis

  • 35.1 Pharmaceutical Supply Chain Management Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Pharmaceutical Supply Chain Management Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Pharmaceutical Supply Chain Management Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer